T 2160/12 (Peptide binding to MHC class-I/IMMATICS BIOTECHNOLOGIES) of 18.05.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T216012.20170518
- Date of decision
- 18 May 2017
- Case number
- T 2160/12
- Petition for review of
- -
- Application number
- 08785106.9
- IPC class
- A61K 39/00C07K 14/47
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Novel immunogenic epitopes for immunotherapy
- Applicant name
- Immatics Biotechnologies GmbH
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 113(1)European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 83European Patent Convention Art 84
- Keywords
- Novelty - (yes)
Sufficiency of disclosure - (yes)
Claims - clarity (yes)
Amendments - allowable (yes)
Right to be heard - substantial procedural violation (no)
Appeal decision - remittal to the department of first instance (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted for further prosecution on the basis of claims 1 to 12 of the main request filed with letter dated 11 May 2017.
3. The request for reimbursement of the appeal fee is refused.